TMT. N. Maksimova

T. N. Maksimova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


T. N. Maksimova has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A differentiated approach to the diagnosis and treatment of mental disorders in a patient with Ehlers-Danlos syndrome (clinical observation)

    by N. A. Tyuvina, T. N. Maksimova, D. A. Golovkina, T. V. Segal, F. A. Litvin

    Somatic and neurological hereditary disorders, which arise as a result of various genetic mutations and usually manifest from childhood, are often accompanied by various mental health disorders. These may include mental disorders of exogenous-organic origin, personality disorders that are exacerbated or develop against a background of prolonged, severe, disabling illness with reactions of decompensation and maladjustment; endogenous disorders may also occur comorbidity. Mental disorders in themselves complicate the clinical picture, reduce quality of life and exacerbate social maladjustment. Furthermore, mental disorders, particularly those of an anxiety-depressive nature, can aggravate somatic pathology via a psychosomatic mechanism, a factor that must be taken into account when providing care for such patients. To illustrate the above, we present a clinical case of a patient with Ehlers–Danlos syndrome (a hereditary connective tissue dysplasia), which manifests, in addition to musculoskeletal pathology, as pronounced cardiovascular, neurological and mental disorders. The latter are represented by an organic personality disorder of a predominantly hysterical nature with anxiety-depressive maladaptive reactions. The difficulties of differential diagnosis of personality disorders and therapeutic aspects are discussed.

  • Open Access

    Difficulties in the diagnosis of depression in somatic and neurological practice: clinical observation

    by N. A. Tyuvina, T. N. Maximova, S. V. Prokhorova, E. A. Kamelina

    Depression often develops on a background of somatic and neurological conditions, but the relationship and mutual influence of these disorders can be different. Depression can be exogenous-organic in the context of somatic and neurological diseases; it can be a nosogenic reaction to the disease. In somatic and neurological patients, endogenous depression can be observed as a comorbid depressive episode of a recurrent depressive disorder or a bipolar affective disorder. However, patients' somatic complaints often mask the psychopathological picture of the depression and make its diagnosis more difficult. Conversely, depression can trigger or aggravate somatic condition via psychosomatic mechanisms, which is of great importance for the care providers of these patients. To illustrate the above, we present a clinical observation in which a patient with a history of two traumatic brain injuries with subsequent hospitalizations, long-term alcohol abuse, hepatitis B and C, accompanied by antiviral therapy, was diagnosed with recurrent depressive disorder (current episode – depressive hypochondriacal). Difficulties in the diagnosis of depression, aetiopathogenetic and therapeutic aspects are discussed.


  • Prevalence and risk factors of delirium in COVID-19

    by Yu.G. Tikhonova, M.A. Kinkulkina, A.V. Volkov, V.A. Sedelkova, T.I. Avdeeva, T.A. Izyumina, M.A. Makarova, T.N. Maximova, M.YU. Brovko, S.V. Moiseev, et al.

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка распространенности и факторов риска развития делирия у госпитализированных пациентов с новой коронавирусной инфекцией (COVID-19). МАТЕРИАЛ И МЕТОДЫ Обследованы 440 пациентов, поступивших в инфекционный госпиталь Университетской клинической больницы №3 Сеченовского Университета с COVID-19. Использовались психометрические шкалы: опросник здоровья пациента (PHQ-9), скрининговый опросник генерализованного тревожного расстройства-7 (GAD-7), шкала оценки тяжести бессонницы (ISI), шкала оценки тяжести делирия (DRS-R-98). РЕЗУЛЬТАТЫ Делирий выявлен у 27,8% больных. Значимыми факторами риска являлись возраст (p=0,002), тяжесть дыхательной недостаточности (p=0,005), наличие сопутствующей соматической патологии (p=0,003), проведение респираторной терапии (ppp=0,07), наблюдаемых при поступлении, с риском развития делирия в течение срока госпитализации. ЗАКЛЮЧЕНИЕ Обнаружена высокая распространенность развивающегося при COVID-19 делирия. Для его предотвращения и/или снижения риска развития особое значение приобретают ранняя диагностика и выявление доклинических форм.

  • Open Access

    Mental disorders during the pandemic of a new coronavirus infection: clinical features

    by V. A. Vysokova, N. A. Tyuvina, T. N. Maksimova, S. V. Prokhorova

    Objective: to study the clinical features of mental disorders during the COVID-19 epidemic in those who turned to psychiatrist for the first time, as well as in patients with already diagnosed mental illness.Material and methods. We examined 100 patients who turned to psychiatrist due to deterioration of their mental state on the background of a pandemic. Of these, 50 were new cases (1st group; 23 women and 27 men, mean age 34 years) and 50 were cases with previously diagnosed mental disorders (2nd group; 25 women and 25 men, mean age 37 years). 80% of patients of the 1st group, 54% of patients of the 2nd group had coronavirus infection. Anxiety and depressive disorders prevailed in the 1st group, endogenous diseases prevailed in the 2nd group: bipolar affective disorder, recurrent depressive disorder, schizophrenia. The study was conducted by the clinical method using a specially designed map; the severity of depression was assessed using the Montgomery-Asberg Depression Rating Scale, and the severity of anxiety was assessed using the Hamilton Anxiety Rating Scale.Results. The clinical picture of primary and recurrent depressive episodes after infection was characterized by the presence of motor and associative retardation, severe apathy, hypersomnia and lack of sleep, fatigue, increased appetite, and complaints of impaired attention and memory. Depression in SARS-CoV-2 survivors was characterized by anxiety, anhedonia, irritability, somatic complaints, and hypochondriacal inclusions. Anxiety symptoms in those who were not ill included severe anxiety, reaching agitation, disturbed sleep with frequent awakenings, irritability, somatic complaints, and hypochondriacal fixation on one’s condition. In recovering patients, anxiety was accompanied by control of somatic functions, cognitive impairments, and fear of retention or even intensification.Conclusion. The results obtained indicate the existing differences between the mental disorders that first appeared and worsened during the pandemic, as well as the differences in the structure of the depressive and anxiety syndrome depending on the presence or absence of coronavirus infection.

  • Open Access

    Causes and predictors of mental disorders during the COVID-19 pandemic

    by N. A. Tyuvina, V. O. Vysokova, T. N. Maksimova, S. V. Prokhorova

    Causes and predictors of mental disorders during the COVID-19 pandemic